10-Q: 22nd Century Group Reports Q1 2025 Results: Revenue Declines, Focus Remains on Tobacco Harm Reduction

22nd Century Group's Q1 2025 results show a revenue decrease of 7.9% year-over-year, with ongoing efforts to manage debt and pursue financing strategies amid going concern uncertainty.

Summary

• 22nd Century Group reported net revenues of $5.956 million for Q1 2025, a 7.9% decrease compared to $6.469 million in Q1 2024.
• The company experienced a gross loss of $609,000 in Q1 2025, an improvement from the $1.129 million loss in the same period last year.
• Operating expenses decreased to $1.961 million from $3.305 million year-over-year, driven by lower sales, general, and administrative expenses, as well as reduced research and development costs.
• The operating loss from continuing operations was $2.570 million, compared to $4.434 million in the prior year period.
• Net loss from continuing operations was $3.274 million, with a basic and diluted loss per common share of $1.89.
• As of March 31, 2025, the company's cash and cash equivalents stood at $1.133 million.
• There is substantial doubt about the company's ability to continue as a going concern through one year following the date that the Condensed Consolidated Financial Statements are issued.
• Management is evaluating strategies to reduce expenses and pursue financing options, including raising funds through securities issuance, asset sales, and strategic partnerships.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the company is taking steps to reduce expenses and improve its financial position, the going concern warning and revenue decline are significant concerns. The recent warrant inducement provides some short-term relief, but the long-term outlook remains uncertain.

Positives

• Gross loss improved compared to the prior year, driven by stabilized volume under new customer contracts and product mix.
• Operating expenses significantly decreased due to lower headcount, strategic consulting expenses, and legal expenses.
• Interest expense decreased due to ongoing debt repayment and elimination of debt obligations.
• The company is actively pursuing strategies to reduce expenses and raise capital.
• The company received approximately $5.1 million in net proceeds from the inducement and exercise of warrants subsequent to quarter end.

Negatives

• Net revenues decreased by 7.9% year-over-year.
• The company reported a gross loss for the quarter.
• The company has an accumulated deficit of $398.199 million as of March 31, 2025.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company had a working capital deficit from continuing operations of ($5.201) million as of March 31, 2025.

Risks

• The company faces risks related to the lack of available capital and potential covenant non-compliance with its Senior Secured Credit Facility.
• Unsuccessful commercialization strategy and lack of market acceptance of the company's products pose significant risks.
• The company is subject to risks inherent in litigation, including purported class actions.
• Failure to protect proprietary technology could adversely affect the company's business.
• The company's ability to continue as a going concern is uncertain, and management's plans may not alleviate this doubt.

Future Outlook

Management is currently evaluating different strategies for reducing expenses, as well as pursuing financing strategies which include raising additional funds through the issuance of securities, asset sales, and through arrangements with strategic partners. The company is also working to rebrand and relaunch its VLN cigarette product.

Management Comments

• Management is currently evaluating different strategies for reducing expenses, as well as pursuing financing strategies which include raising additional funds through the issuance of securities, asset sales, and through arrangements with strategic partners.

Industry Context

22nd Century Group operates in the tobacco industry, specifically focusing on harm reduction through reduced nicotine content cigarettes. The company's flagship product, VLN, has received MRTP authorization from the FDA, positioning it to potentially capture a segment of the market focused on health and wellness. The company also competes in the contract manufacturing space for tobacco products.

Comparison to Industry Standards

• It's difficult to directly compare 22nd Century Group's results to industry standards without knowing the specific performance of its direct competitors in the reduced nicotine cigarette market.
• However, the overall tobacco industry is dominated by large players like Philip Morris International, British American Tobacco, and Altria Group, which have significantly larger revenue bases and established distribution networks.
• 22nd Century Group's focus on reduced nicotine content cigarettes differentiates it from traditional tobacco companies, but it also faces the challenge of educating consumers and gaining market share in a competitive landscape.
• The company's contract manufacturing operations compete with other CMOs in the tobacco industry, where pricing and efficiency are key factors for success.

Legal Proceedings

• The company is involved in several legal proceedings, including a shareholder derivative case, an insurance litigation, a dispute with Keygene N.V., and a dispute with Cookies Retail Products, LLC.
• The company is also defending against a complaint filed by a former employee related to a fire at the company's Grass Valley manufacturing facility.

Related Party Transactions

• The Company generated revenue from a related party contract manufacturing customer.
• During the three month period ended March 31, 2025, private label cigarette revenue, net and corresponding contract asset from the related party were not material.

Stakeholder Impact

• Shareholders face the risk of further dilution and potential loss of investment due to the company's financial difficulties.
• Employees may be affected by cost-cutting measures and potential layoffs.
• Customers may experience disruptions in product availability if the company is unable to secure sufficient funding.
• Suppliers and creditors face the risk of non-payment if the company's financial situation deteriorates.

Next Steps

• The company will hold a meeting of stockholders to approve the issuance of shares of common stock underlying the Inducement Warrants.
• The company will continue to pursue strategies to reduce expenses and raise capital.
• The company plans to launch the rebranded VLN cigarette product in the second quarter of 2025.

Key Dates

Keywords

tobacco harm reduction, reduced nicotine content, VLN, contract manufacturing, financial results, going concern, warrants, debt, liquidity, 22nd Century Group